Related Experiment Video
Updated: Aug 6, 2026
03:47
Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
Published on: July 12, 2024
Building Collaborative Heart Failure Care Through a Community Pharmacy Certificate Program and Community
Kazuhiko Kido1, Amber Conrad2, Ryan Vilain3
1Department of Clinical Pharmacy, West Virginia University School of Pharmacy, Morgantown, West Virginia, USA.
JACC. Advances
|July 23, 2026
Summary
Community pharmacists can effectively manage heart failure (HF) through specialized training. A pilot program demonstrated their ability to provide comprehensive HF education and interventions, improving patient care.
Area of Science:
- Cardiology
- Pharmaceutical Sciences
- Public Health
Background:
- Limited evidence exists on community-based heart failure (HF) care involving community pharmacists.
- Community pharmacy's role in chronic disease management is expanding.
Purpose of the Study:
- To evaluate the impact of collaborative HF care facilitated by a community pharmacy certificate program.
- To assess new partnerships between community pharmacists and healthcare providers.
Main Methods:
- A 1-year prospective cohort pilot study.
- Community pharmacists received specialized HF education via a certificate program.
- 34 adult HF patients received comprehensive education and interventions over 6 months.
Main Results:
- Three pharmacists completed the program and passed certification exams.
- 80 interventions were performed, with 37.5% acceptance rate.
- Accepted interventions included vaccinations, adherence support, and guideline-directed medical therapy optimization.
Conclusions:
- A HF community pharmacy certificate program effectively prepared pharmacists for collaborative care.
- Certified pharmacists provided comprehensive patient education and clinical interventions.
- This supports the significant potential role of community pharmacists in HF management.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...